WCA
RMD icon

Westover Capital Advisors’s ResMed RMD Stock Holding History

Westover Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,447
Closed -$502K – 125
2017
Q2 		$502K Sell
6,447
-98
-1% -$7.01K 0.33% 66
2017
Q1 		$471K Sell
6,545
-60
-0.9% -$4.15K 0.31% 74
2016
Q4 		$410K Sell
6,605
-9,443
-59% -$578K 0.29% 71
2016
Q3 		$1.04M Buy
16,048
+616
+4% +$41K 0.77% 45
2016
Q2 		$976K Buy
+15,432
New +$910K 0.8% 43

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Westover Capital Advisors's RMD Position: Q3 2017 in Review

Westover Capital Advisors sold out of ResMed (RMD) in Q3 2017, closing a stake of 6,447 shares — an estimated $502K sold.

Westover Capital Advisors first reported a position in RMD in Q2 2016 and held it in 5 quarters. The position peaked at $1.04M in Q3 2016. 362 funds tracked by Wall St. Rank hold RMD as of Q3 2017.

  • Westover Capital Advisors reported no remaining ResMed position as of Q3 2017 after selling out during the quarter.
  • Westover Capital Advisors sold 6,447 ResMed shares in Q3 2017, an estimated $502K.
  • Westover Capital Advisors first reported a position in ResMed in Q2 2016 and held it in 5 quarters.
  • Westover Capital Advisors's ResMed position peaked at $1.04M in Q3 2016.
  • 362 funds tracked by Wall St. Rank held ResMed as of Q3 2017.

Based on Westover Capital Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.